Abstract:
An apparatus for collecting spent ammunition casings from a weapon is disclosed. The apparatus has a support assembly, a container attached to the support assembly and forming a cavity configured to receive the ammunition casings, and a fastener configured to be received in a portion of a mounting fixture of the weapon and removably attach the support assembly to the mounting fixture. The fastener is either a replacement fastener or a modified fastener of a mounting fixture fastener of the weapon.
Abstract:
The present invention generally relates to a firearm shell casing receiver. The invention generally comprises of a horseshoe shaped member with widened ends and an arm member that serves as a clip to allow for the attachment of a receiver vesicle. To utilize the current invention, the shell casing receiver securely grips onto a firearm's platform whereas the clip portion holds a receiver vesicle to capture any spent ammunition.
Abstract:
The present invention generally relates to a firearm shell casing receiver. The invention generally comprises of a horseshoe shaped member with widened ends and an arm member that serves as a clip to allow for the attachment of a receiver vesicle. To utilize the current invention, the shell casing receiver securely grips onto a firearm's platform whereas the clip portion holds a receiver vesicle to capture any spent ammunition.
Abstract:
An insulin analog comprises a B-chain polypeptide incorporating a chlorinated phenylalanine. The chlorinated phenylalanine may be located at position B24. The chlorinated phenylalanine may be para-monochloro-phenylalanine. The analog may be of a mammalian insulin, such as human insulin. A nucleic acid encodes such an insulin analog. The chlorinated insulin analogs retain significant activity. A method of treating a patient comprises administering a physiologically effective amount of the insulin analog or a physiologically acceptable salt thereof to a patient. Chlorine substitution-based stabilization of insulin may reduce fibrillation and thereby enhance the treatment of diabetes mellitus in regions of the developing world lacking refrigeration.
Abstract:
The present invention relates to navigating in a geographic information system. In an embodiment, a method tours geographic information in a geographic information system. A set of actions for a tour is received. Each action includes a tour time. A tour time of at least one of the actions is defined by a user. Each action in the set of actions is executed to tour geographic information in the geographic information system.
Abstract:
An optical measuring system includes at least one radiation source, at least one radiation receiver, and at least one flow through cell. The radiation emitted by the at least one radiation source passes at least partially in an optical path between the radiation source and the radiation receiver through the flow through cell and then strikes the at least one radiation receiver. The radiation receiver is embodied to output a signal dependent on the intensity of the radiation striking the radiation receiver, wherein the flow through cell is arranged in a cell holder, which is connected via a first connection interface releasably with the radiation receiver and which is connected via a second connection interface releasably with the radiation source.
Abstract:
An insulin analogue comprises a B-chain polypeptide incorporating a chlorinated phenylalanine. The chlorinated phenylalanine may be located at position B24. The chlorinated phenylalanine may be para-monochloro-phenylalanine. The analogue may be of a mammalian insulin, such as human insulin. A nucleic acid encodes such an insulin analogue. The chlorinated insulin analogues retain significant activity. A method of treating a patient comprises administering a physiologically effective amount of the insulin analogue or a physiologically acceptable salt thereof to a patient. Chlorine substitution-based stabilization of insulin may reduce fibrillation and thereby enhance the treatment of diabetes mellitus in regions of the developing world lacking refrigeration.
Abstract:
An insulin analogue comprises a B-chain polypeptide incorporating a chlorinated phenylalanine. The chlorinated phenylalanine may be located at position B24. The chlorinated phenylalanine may be para-monochloro-phenylalanine. The analogue may be of a mammalian insulin, such as human insulin. A nucleic acid encodes such an insulin analogue. The chlorinated insulin analogues retain significant activity. A method of treating a patient comprises administering a physiologically effective amount of the insulin analogue or a physiologically acceptable salt thereof to a patient. Chlorine substitution-based stabilization of insulin may reduce fibrillation and thereby enhance the treatment of diabetes mellitus in regions of the developing world lacking refrigeration.
Abstract:
A controllable coolant pump for a coolant circuit of an internal combustion engine. The coolant pump has a hollow bearing shaft which is supported in a bearing sleeve, carries a drive wheel at one end, and is permanently connected to an impeller at its opposite end, the impeller having a stop surface at the end face thereof. The space between the stop surface and the impeller forms the pumping cross section for a coolant. A piston that can be axially displaced by an actuation unit is disposed in the hollow bearing shaft and provided at its outer end with a guide plate having a collar facing the impeller for completely or partially closing the pumping cross section in accordance with the position of the piston. The coolant pump has a second actuation unit, and the piston can be displaced by the first or second actuation unit.
Abstract:
A number of thalidomide metabolites having superior anti-angiogenic properties have now been isolated and identified. In addition, thalidomide analogs that mimic the effects of the isolated and identified active thalidomide metabolites, and variations of such thalidomide analogs, have been developed. Such thalidomide analog compounds show enhanced potency in the inhibition of undesirable angiogenesis without the undesirable effects of administration of thalidomide.